Bronte Capital Management Pty Ltd. has filed its 13F form on February 10, 2025 for Q4 2024 where it was disclosed a total value porftolio of $984 Million distributed in 24 stocks.

Among their holdings, we can observe that their the top five positions include companies like: Ishares Core S&P Sm Cap ETF with a value of $163M, Regeneron Pharmaceuticals, Inc. with a value of $109M, Interactive Brokers Group, Inc. with a value of $105M, Alphabet Inc. with a value of $101M, and Berkshire Hathaway Inc Class B with a value of $99.6M.

Examining the 13F form we can see an decrease of $138M in the current position value, from $1.12B to 984M.

Below you can find more details about Bronte Capital Management Pty Ltd. portfolio as well as his latest detailed transactions.

Portfolio value $984 Million
Financial Services: $303 Million
ETFs: $198 Million
Communication Services: $160 Million
Healthcare: $109 Million
Consumer Defensive: $88.2 Million
Consumer Cyclical: $79.6 Million
Basic Materials: $37.7 Million
Technology: $9.7 Million
Other: $0

Stock Holdings Table ETFs Only

Stock Market Cap. Holding Value (Reported) # of Shares. Last Trade Trade History

Summary

  • Portfolio
  • No. of Stocks 24
  • Current Value $984 Million
  • Prior Value $1.12 Billion
  • Filing
  • Period Q4 2024
  • Filing Date February 10, 2025
  • Form Type 13F-HR
  • Activity in Q4 2024
  • New Purchases 0 stocks
  • Additional Purchases 3 stocks
  • Sold out of 0 stocks
  • Reduced holdings in 21 stocks
Track This Portfolio

Track Bronte Capital Management Pty Ltd. Portfolio

Follow Bronte Capital Management Pty Ltd. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Bronte Capital Management Pty Ltd., based on Form 13F filings with the SEC.

News

Stay updated on Bronte Capital Management Pty Ltd. with notifications on news.